This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
SAN DIEGO, March 15, 2011 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) expects to announce its 2010 financial results for the fourth quarter and fiscal year before the market opens on Monday, March 28, 2011.
TearLab is pleased to invite all interested parties to participate in a conference call during which time financial results will be discussed. The call will be held on March 28, 2011, at 8:30a.m. Eastern Daylight Savings Time at 877-303-1593 (within the United States and Canada).
For those wishing to listen to a recording of the call via telephone, a replay will be made available by 11:30am EDT after the conclusion of the live call and will remain posted for a period of seven days. To listen to the recording, simply telephone (800) 642-1687 or (706) 645-9291 and enter reservation # 52311846 when prompted.
About TearLab Corporation
TearLab Corporation (
www.tearlab.com) develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The TearLab(r) Osmolarity Test, that enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care, is the first assay developed for the award winning TearLab Osmolarity System. Headquartered in San Diego, CA, TearLab Corporation's common shares trade on the NASDAQ Capital Market under the symbol 'TEAR' and on the Toronto Stock Exchange under the symbol 'TLB'.